AstraZeneca's new wonderdrug produces 'significant reduction' in severe Covid and death

The group’s treatment, known as AZD7442, is a combination of two antibodies and has been undergoing final clinical trials.

AstraZeneca has announced it achieved a “statistically significant reduction in severe COVID-19 or death” in non-hospitalised patients with mild-to-moderate symptoms.


Leave a Reply

Your email address will not be published.